Ovarian Cancer Heroes 2020

Survivors and experts share what to do before your first chemo infusion, from scalp cooling and saving your hair to skin care and building a support team.

After two relapses of acute lymphoblastic leukemia, Hannah Koepsell received CAR-T cell therapy. A pediatric oncologist explains why leukemia can return after treatment and how researchers are working to make CAR-T responses last longer.

FDA approves Welireg plus Lenvima for advanced clear cell kidney cancer after PD-1 or PD-L1 treatment, offering a new treatment option.

These seven breast cancer clinical trials are recruiting patients now, spanning early-stage, HR-positive, HER2-positive and triple-negative disease.

Two sisters discover they share a BRCA2 mutation, but choose different paths to manage their breast cancer risk and navigate life as previvors.

After 18 years with multiple myeloma, Sally Kalksma shares 10 people, places and things that helped her stay strong through cancer treatment.

In the latest installment of CURE's "Text a Survivor" series, Brad Moore answers some of the most common questions people have about living with and beyond a colorectal cancer diagnosis.

Lyrfigtu was approved for adults with previously treated cholangiocarcinoma with an FGFR2 gene fusion or other rearrangement.